Danaher Corporation (NYSE:DHR) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market.
Cramer called it a “one-time excellent company,” as he said: For instance, Danaher, another one-time excellent company, has seen the stock just get pulverized after not-so-great quarters, or I should say a savage string of not-so-great quarters
The stock of the medical and diagnostic company is down… 27% year to date, and just head shaking, this is Danaher. Those two, of course, aren’t alone. Boston Scientific, Intuitive Surgical, Medtronic, ResMed, Stryker, Zimmer Biomet, they all hit new lows.
That’s a remarkable confluence of true ugliness from some pretty darn good companies. Photo by Adam Nowakowski on Unsplash Danaher Corporation (NYSE:DHR) provides instruments, consumables, software, and services used in bioprocessing, life sciences research, and clinical diagnostics. Cramer mentioned the stock during the January 23 episode and commented: CNBC Investing Club members, look out.